Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  BioMarin Pharmaceutical Inc.    BMRN

Delayed Quote. Delayed  - 08/25 10:00:00 pm
94.97 USD   -0.17%
08/25 BIOMARIN PHARMA : Forbes Ranks BioMarin 10th Most Innovative Company..
08/24 Forbes Ranks BioMarin 10th Most Innovative Company in the World
08/22 NASDAQ 100 MOVE : Viab, incy
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo BioMarin Pharmaceutical In
Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions

BioMarin Pharmaceutical, Inc. engages in the development and commercialization of innovative pharmaceuticals for serious diseases and medical conditions.

It operates its business through one segment, the biopharmaceutical development and commercialization segment.

Its company's products include Naglazyme, Kuvan, Aldurazyme, Firdapse and VIMIZIM.

The company was founded on March 21, 1997 and is headquartered in Novato, CA.

Number of employees : 2 158 persons.
Sales per Businesses
20142015Delta
USD (in Million)%USD (in Million)%
Biopharmaceutical Development and Commercialization751.04100.1%889.90102% +18.49%
Sales per Regions
20142015Delta
USD (in Million)%USD (in Million)%
United States380.0450.7%444.0850.9% +16.85%
Europe139.9418.7%178.7520.5% +27.73%
Latin America118.5615.8%142.3116.3% +20.03%
Rest of World112.4915%124.7714.3% +10.91%
Managers
NameAgeSinceTitle
Jean-Jacques Bienaimé622005Chairman & Chief Executive Officer
Daniel K. Spiegelman, MBA572012Chief Financial Officer & Executive Vice President
Henry J. Fuchs, MD582009Chief Medical Officer & Executive Vice President
Eduardo E. Von Pervieux, MBA-2008Chief Information Officer & Vice President
Pierre LaPalme752004Director
Elaine J. Heron PhD, MBA682002Independent Non-Executive Director
Mike G. Grey632005Independent Non-Executive Director
Richard A. Meier562006Lead Independent Non-Executive Director
V. Bryan Lawlis Jr., PhD642007Independent Non-Executive Director
Alan J. Lewis, PhD702005Independent Non-Executive Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 170,782,081 170,169,286 99.6% 0 0.0% 99.6%
Shareholders
NameEquities%
Capital Research & Management Co. (Global Investors) 15,853,303 9.77%
The Vanguard Group, Inc. 11,448,690 7.05%
Sands Capital Management LLC 10,918,317 6.73%
Fidelity Management & Research Co. 9,970,031 6.14%
Jennison Associates LLC 9,051,244 5.58%
BlackRock Fund Advisors 7,655,321 4.72%
PRIMECAP Management Co. 7,319,319 4.51%
Baker Bros. Advisors LP 4,806,483 2.96%
T. Rowe Price Associates, Inc. 3,525,314 2.17%
Temasek Holdings Pte Ltd. (Investment Management) 3,472,712 2.14%
Holdings
NameEquities%Valuation
Catalyst Pharmaceuticals Inc (CPRX) 6,666,6678.04%4,800,000 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Generic Pharmaceuticals
Advertisement
Sector Generic Pharmaceuticals
1st jan.Capitalization (M$)
BIOMARIN PHARMACEUTICA..-9.35%16 246
SUN PHARMACEUTICAL IND..-5.88%27 613
OTSUKA HOLDINGS CO LTD6.76%25 779
ONO PHARMACEUTICAL CO...-35.19%16 843
ASPEN PHARMACARE HOLDI..17.77%11 536
TAISHO PHARMACEUTICAL ..15.21%8 963
SHANGHAI FOSUN PHARMAC..-3.53%7 642
CIPLA LTD-13.15%6 794
CADILA HEALTHCARE LIMI..0.00%5 743
HANMIPHARM--.--%5 666
DIVI'S LABORATORIES LT..17.63%5 334
ENDO INTERNATIONAL PLC-65.65%4 921
SHENZHEN SALUBRIS PHAR..--.--%4 574
HUNAN ER-KANG PHARMACE..--.--%4 326
CHINA MEDICAL SYSTEM H..13.61%4 269
RICHTER GEDEON VEGYESZ..--.--%3 848
ZHEJIANG NHU COMPANY L..--.--%3 683
GLENMARK PHARMACEUTICA..-6.66%3 601
HUBEI JUMPCAN PHARMACE..7.01%3 601
STADA ARZNEIMITTEL AG28.98%3 417
HAISCO PHARMACEUTICAL ..--.--%2 977
Sector Generic Pharmaceuticals
BioMarin Pharmaceutical In : Connections
Targazyme, Inc.
Algorithme Pharma, Inc.
DiaVacs, Inc.
AbSci LLC
Zephyrus Biosciences, Inc.
Amplyx Pharmaceuticals, Inc.
Cellastra, Inc.
Reneo Pharmaceuticals, Inc.
Rincon Pharmaceuticals, Inc.
Pediapharm Inc
GLyPharma Therapeutic, Inc.
GlycoFi, Inc.
Reform Biologics LLC
Ziarco Group Ltd.
Ziarco Pharma Ltd.
Selventa, Inc.
Sutro Biopharma, Inc.
Rapidscan Pharma Solutions, Inc.
Cytochroma, Inc.
Balance Therapeutics, Inc.
Batu Biologics, Inc.
A. M. Pappas & Associates LLC
Sosei Co. Ltd.
Biotechnology Innovation Organization
Itero Biopharmaceuticals LLC
Capella Therapeutics, Inc.
Company contact information
770 street Lindaro
CA 94901 San Rafael, California
États-Unis (les)

Phone : +1 415 506 6700
Fax : +1 415 382 7889
Internet : http://www.bmrn.com
Markets and indexes
- NASDAQ All Markets
- Nasdaq Global Select Market
- Nasdaq 100 /
Stock Exchange Codes
- ISIN Code :  US09061G1013
- Bloomberg Code :  
- Reuters Code :  BMRN.O
- Datastream Code :  
© 2016 People , Fundamentals and Ownership    © 2016 Cofisem